Sparc technologies’ recently established bio-medical division aims to improve health outcomes and disease identification and management
- Project underway to develop non-invasive sensing devices for detection of diseases in both humans and animals via graphene based sensors
- Focus of the project will be on research and development of graphene-based sensing devices
- Initial work by Sparc, in collaboration with University of Adelaide, will include development/fabrication of lab-scale sensing devices
Technical Lead – Bio-Medical
Mr Yerbury has over 20-years’ experience in the global medical device industry with Fortune 500 organisations including ResMed, Baxter Healthcare, Boston Scientific and Zimmer Biomet. His experience spans a broad range of clinical specialties and technologies across the respiratory and cardiovascular fields to orthopaedics and general surgery, to infusion therapy and nephrology.
Mr Yerbury brings a wealth of experience across Australia and New Zealand, Asia Pacific and European markets and their respective reimbursement models and regulatory environments, which will be invaluable to Sparc’s commercialisation and development strategies. Mr Yerbury has direct and wide expertise in launching new, disruptive, technologies and business models to accelerate business growth and build competitive advantages in the medical device industry.